Patient Square Capital’s Harrow HROW Stock Holding History

Patient Square Capital’s Portfolio HROW Stock Details HROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-165,209	Closed	-$5.83M	–	28
2026 Q1	$5.83M	Buy	165,209 +158,178	+2,250%	+$6.95M	1.03%	24
2025 Q4	$345K	Buy	+7,031	New	+$295K	0.07%	28

Other funds holding HROW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

PCMF

Private Capital Management (Florida) Naples, Florida $1.14B AUM 34.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Patient Square Capital's HROW Position: Q2 2026 in Review

Patient Square Capital sold out of Harrow (HROW) in Q2 2026, closing a stake of 165,209 shares — an estimated $5.83M sold.

Patient Square Capital first reported a position in HROW in Q4 2025 and held it in 2 quarters. The position peaked at $5.83M in Q1 2026. 223 funds tracked by Wall St. Rank hold HROW as of Q2 2026.

Patient Square Capital reported no remaining Harrow position as of Q2 2026 after selling out during the quarter.
Patient Square Capital sold 165,209 Harrow shares in Q2 2026, an estimated $5.83M.
Patient Square Capital first reported a position in Harrow in Q4 2025 and held it in 2 quarters.
Patient Square Capital's Harrow position peaked at $5.83M in Q1 2026.
223 funds tracked by Wall St. Rank held Harrow as of Q2 2026.

Based on Patient Square Capital's 13F filing for Q2 2026, filed 12 Aug 2026.